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Mechanistic insights into allosteric regulation of
the A2A adenosine G protein-coupled receptor by
physiological cations
Libin Ye1,2, Chris Neale3, Adnan Sljoka4, Brent Lyda5, Dmitry Pichugin1,2, Nobuyuki Tsuchimura4,
Sacha T. Larda1,2, Régis Pomès 2,6, Angel E. García3, Oliver P. Ernst 2,7, Roger K. Sunahara 5 &
R. Scott Prosser1,2
Cations play key roles in regulating G-protein-coupled receptors (GPCRs), although their
mechanisms are poorly understood. Here, 19F NMR is used to delineate the effects of cations
on functional states of the adenosine A2A GPCR. While Na+ reinforces an inactive ensemble
and a partial-agonist stabilized state, Ca2+ and Mg2+ shift the equilibrium toward active
states. Positive allosteric effects of divalent cations are more pronounced with agonist and a
G-protein-derived peptide. In cell membranes, divalent cations enhance both the affinity and
fraction of the high affinity agonist-bound state. Molecular dynamics simulations suggest
high concentrations of divalent cations bridge specific extracellular acidic residues, bringing
TM5 and TM6 together at the extracellular surface and allosterically driving open the
G-protein-binding cleft as shown by rigidity-transmission allostery theory. An understanding
of cation allostery should enable the design of allosteric agents and enhance our
understanding of GPCR regulation in the cellular milieu.
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Humans have over 800 G-protein-coupled receptors(GPCRs), whose capacities to accomplish signalingthrough interaction with intracellular partners are
regulated by extracellular ligands. GPCRs are by no means simple
ligand-activated on/off switches and are best represented in terms
of an ensemble of multiple inactive, intermediate, and active
receptor states1–3. The relative populations of these states are
influenced by many cell constituents, including physiological
cations4–6. For instance, early ligand binding studies of opiate
receptors in rat brain homogenate showed that sodium increased
antagonist affinity while decreasing agonist affinity7. In contrast,
divalent Mg2+, Ca2+, and Mn2+ enhanced binding of μ-, δ-, and
κ-opioid receptor agonists in brain homogenates8,9.
Allosteric effects of Mg2+, Ca2+, and Na+ have been observed
with A2AR10–12 and the muscarinic M2 receptor13, while Ca2+ is
known to allosterically regulate many family C GPCRs14–16. Most
recently, high-resolution crystallographic studies of A2AR, the
δ-opioid receptor, PAR1 protease activated receptor, and the
β1-adrenergic receptor show that Na+ plays an integral role in
stabilizing a functionally inactive conformational state17–20. In
particular, the 1.8 Å X-ray crystal structure of A2AR (PDB ID:
4EIY) revealed an Na+ pocket, coordinated by water molecules
and several highly conserved residues, including D522.50, S913.39,
W2466.48, and N2847.49 (superscripts refer to the Ballesteros and
Weinstein nomenclature21). The charged groups lining this
pocket interface with an almost contiguous network of water
molecules spanning the transmembrane domain and linking
transmembrane helices (TM) 1, 2, 3, 6, and 7 in the inactive state.
Remarkably, the sodium pocket appears to be a common facet of
most non-olfactory class A receptors22,23, although much less is
known about binding sites associated with divalent cations and
their underlying allosteric mechanisms.
Due to the exceptional sensitivity of the fluorine nuclear spin to
electrostatic environment, 19F NMR has been used to quantita-
tively monitor conformational equilibria in GPCRs1–3,24. Using a
next-generation thiol-specific trifluoromethyl tag, this metho-
dology was applied to A2AR, revealing an ensemble of inactive
states in which a stabilizing ionic lock between R1023.50 and
E2286.30 flickers on a millisecond timescale between an on-state
(S1) and off-state (S2)2, in slow exchange with two distinct acti-
vation intermediates, S3 and S3′1. Interestingly, the relative
populations of S3 and S3′ were increased by partial and full
agonist, respectively.1 The activation process can be viewed from
the perspective of a free energy landscape, wherein ligands
influence both the populations and lifetimes of key functional
states. In the current study, we make use of the identical trun-
cated version of human A2AR (2-317) containing a single cysteine
mutation (V229C6.31), which was labeled with a trifluoromethyl
moiety (BTFMA)25. Upon reconstituting A2AR in MNG-3
detergent micelles, 19F NMR revealed the effect of the mono-
and divalent cations on the balance of states, and their interplay
with orthosteric ligands and a peptide derived from the C-
terminal domain of the α subunit of the stimulatory G protein
(i.e. Gαs peptide). Traditional radioligand binding assays of the
identical construct either by itself or co-expressed with G protein
also revealed the allosteric effects of these cations in insect cell
membranes. Interaction dynamics with cations are also key to
understanding cation egress potentially associated with the acti-
vation process. This is demonstrated by 25Mg NMR and 23Na
NMR CPMG relaxation dispersion measurements, which in the
latter case provide a measure of the bound state lifetime of the
sodium ion for apo- A2AR and upon saturation with inverse
agonist. Explicit-solvent all atom molecular dynamics (MD)
simulations of A2AR in a lipid bilayer allow us to predict likely
divalent cation binding sites in the receptor and validate inter-
action dynamics. Subsequent divalent cation bound structures
can then be analyzed using rigidity-transmission allostery (RTA)
algorithms that assess the extent to which cation binding
allosterically influences G protein binding.
Results
Negative allosteric modulation by sodium. While physiological
sodium cation concentrations are around 140 mM, 19F NMR
spectra of MNG-reconstituted A2AR were recorded over a broad
range of sodium concentrations to ascertain the relative effect of
sodium on the conformational ensemble. Figure 1a, c reveals that
the addition of sodium to apo A2AR shifts the equilibrium
toward the inactive ensemble S1−2 and the S3 state, at the expense
of S3′. Here, spectra are deconvolved into three resonances,
referred to as S1−2, S3, and S3′, in keeping with previously
published work1. As discussed previously, T2 relaxation experi-
ments were performed to estimate linewidths that proved key to
obtaining robust deconvolutions.1 The observation that added
sodium increases the fraction of conformers associated with the
inactive ensemble is consistent with prior radioligand binding
studies in rat striatal membranes, which showed sodium slowed
the off-rate of an antagonist26. Thus far, several crystal structures
(Fig. 1b) corroborate the observation of a conserved bound
sodium ion that associated exclusively with the inactive
state17,20,22. Moreover, many class A receptors are believed to
bind sodium through a conserved pocket identified by amino acid
alignments (Fig. 1d)22. The observation that sodium also
increases the S3 population at higher sodium concentrations may
imply a second weaker affinity binding site associated with this
activation intermediate or that the sodium-binding pocket,
identified by crystallography, is still accessible to sodium in this
activation intermediate. We note that control experiments in
which KCl was titrated in the presence of 10 mM or 100 mM
NaCl revealed no significant change in the 19F NMR spectra
(Supplementary Fig. 1), in keeping with previous radioligand
studies of A2AR showing a reduced degree of allosteric effects by
potassium27 or lithium11 salts.
Dynamics of Na+ binding to A2AR revealed by 23Na NMR. An
23Na NMR binding isotherm (Fig. 2a, b) reveals that sodium
undergoes rapid exchange between free and receptor bound
states, with a dissociation constant of 60 mM to apo A2AR.
Amiloride analogs are also potent allosteric compounds suggested
to bind to a region that overlaps the sodium-binding
pocket22,26,28. In keeping with earlier suggestions that sodium
and amiloride analogs act at a common allosteric site26, the
addition of an amiloride analog, 5-(N,N-hexamethylene)amilor-
ide (HMA) was shown to compete with sodium as evidenced by
the weakened response in both line broadening and chemical shift
perturbations in the 23Na NMR binding isotherm (Fig. 2c).
Moreover a docking study (Fig. 2d) also suggests that sodium and
HMA binding to apo A2AR occur at the primary sodium-binding
site defined by Liu et al.17. Relaxation dispersions associated with
23Na CPMG experiments, shown in Fig. 2e, provide an additional
measure of cation binding and exchange dynamics. Assuming
that sodium adopts a simple equilibrium between a bound- and a
free-state, it is possible to extend the above binding isotherms
with 23Na CPMG measurements, which provide a measure of the
bound state lifetime. Via a global fit of 23Na relaxation dispersion
profiles at two magnetic field strengths, the addition of inverse
agonist, ZM241385, increases the bound fraction by 20% and the
average bound state lifetime from 480 μs to 630 μs.
Positive allosteric modulation by divalent cations. In contrast to
Na+, increasing amounts of Ca2+ or Mg2+ shift the equilibrium
of apo A2AR toward the active states, S3 and S3′, as shown in
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Fig. 3a and Supplementary Fig. 2, and corresponding histograms
(Fig. 3d, e). However, these effects are observed only at very high
cation concentrations (i.e. between 100 mM and 500 mM). In
contrast, the response to divalent cation appears to be much
stronger in the presence of full agonist N-ethyl-5′-carboxamido
adenosine (NECA) and Gαs peptide (i.e. the C-terminal helix
from Gαs, known to bind to A2AR29). In this case, the addition of
20 mM Ca2+ or Mg2+ gives rise to a detectable increase in the
proportion of active states, and in particular, S3′ (Fig. 3b–e and
Supplementary Figs. 2b, c). In contrast, this cooperative
enhancement in the active ensemble fraction is not observed
when Ca2+ or Mg2+ are combined with partial agonist. While
both Ca2+ and Mg2+ clearly shift equilibria toward the active
states, their effect on G-protein-binding affinity can be directly
assessed by 19F NMR of the Gαs peptide, which in this case was
tagged by the trifluoromethyl moiety described above.
Building on prior studies1, 19F NMR spectra of labeled peptide
(Supplementary Fig. 3b) show clear line broadening with the
addition of apo A2AR (Supplementary Fig. 3a). Moreover, the
spectra can be deconvolved into two components, one of which is
enhanced through the addition of full agonist (NECA).
The combination of agonist and either Ca2+ or Mg2+ brings
about an even greater enhancement of this second component,
which we ascribe to the Gαs peptide when bound to receptor
(Supplementary Figs. 3a and 3c).
Cooperativity recapitulated by radioligand binding assays. The
above 19F NMR observations are further recapitulated in radi-
oligand binding assays in Sf9 cell membranes in which the
identical A2AR construct was co-expressed with the hetero-
trimeric stimulatory G protein, Gαsβγ. Both Mg2+ and Ca2+ are
shown to significantly enhance [3H]NECA (10 nM) binding with
half-maximal cation concentrations of 350–400 μM while Zn2+,
by contrast, is observed to reduce high affinity binding.
Additionally, Mg2+ and Ca2+ enhance maximal specific [3H]
NECA binding and affinity (Kd) as observed in high affinity
saturation experiments (Fig. 4a, b, respectively). Similar allosteric
effects of Ca2+ and Mg2+ on agonist binding, [3H]CGS-21680,
were observed in studies of A2AR in rat striatal membranes11.
While no effect was observed on NECA inhibition of [3H]
ZM241385 binding in membranes expressing A2AR alone, diva-
lent cations enhanced both the affinity (Khigh) and fraction of
high affinity NECA states when G proteins are co-expressed with
receptor (Fig. 4c, d and Table 1) suggesting that the positive
allostery promoted by Ca2+ and Mg2+ is exclusive to a high
affinity state or some activation intermediate state of A2AR.
Molecular dynamics simulations for divalent cation binding.
To identify potential binding sites for divalent cations, all-atom
MD simulations were performed on active or active-like states of
apo A2AR, in the presence of a large excess of cations, which were
initially randomly distributed. Figures 5 and 6 depict the overall
spatial distribution of cations associated with the receptor, based
on fifteen 1 μs simulations, initiated with crystal structures of
either of three active states determined recently by X-ray crys-
tallography27,30,31. In these simulations, cations frequently bound
to a subset of preferred residues, engaging with polar and (more
commonly) acidic residues, while in some cases becoming par-
tially desolvated (Supplemental Fig. 4). Stable cation-bound
complexes identified by these MD simulations are shown in
Fig. 5 and summarized in Supplementary Table 1. Monovalent
and divalent cations exhibited significantly different binding
patterns. While bound sodium is not present in the active state
crystal structure of A2AR bound to an engineered G protein (PDB
ID: 5G53), MD simulations predict sodium nevertheless samples
a region in the vicinity of residues known to form the sodium
pocket in the inactive state. Generally, binding of divalent cations
to either of two agonist-bound A2AR models (PDB IDs: 2YDO
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Fig. 1 Allosteric modulation of A2AR by the monovalent cation Na+. a 19F NMR spectra of 200 μM BTFMA-labeled A2AR-V229C as a function of Na+
concentration (10mM, 100mM and 500mM NaCl). Three distinct resonances correspond to inactive (S1−2, shown in red) and active states (S3 and S3′,
shown in green and blue, respectively). b Top view showing conserved residues (D2.50, S3.39, W6.48 and N7.49) associated with the sodium pocket of A2AR.
c Population histogram of states, S1−2, S3 and S3′, corresponding to spectra shown in (a). d Alignment of conserved residues associated with the sodium
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and 3QAK) was so similar that the results were averaged. All of
the divalent cation-mediated interactions described below per-
sisted for the duration of the simulation and are classified in
terms of: (i) bridging between acidic residues, as in D170-D261
(Fig. 5b), E151-E161 (Fig. 5c), E151-E169-D170 (Fig. 5d), and
E169-D170 (Fig. 5e), (ii) cross-linking between acidic residues
and surrounding lipid phosphoryl groups, as in the case of E169,
E219, E228, D261, E312, and E212 (Fig. 5g and Supplementary
Table 1), (iii) localization in the vicinity of the orthosteric site and
the sodium-binding pocket, dynamically overlapping both
regions and interacting with acidic residues E131.39 and D522.50
(Fig. 5f), and (iv) inhibition of the ionic lock (i.e., DR3.50Y—
E2286.30) through interaction with E2286.30 (Fig. 5h).
Allosteric propagation of divalent cation bridging. Using the
above MD-derived structures in complex with divalent cations, it
is possible to evaluate their roles in allosteric transmission
using rigidity transmission allostery (RTA) algorithms, which are
based on an extension of the program Floppy Inclusion and Rigid
Substructure Topography (FIRST)32–34. The receptor is first
decomposed into rigid clusters and flexible regions and RTA
algorithms are used to estimate the number of non-trivial degrees
of freedom in the system. Binding at one site introduces new local
constraints and thus, a perturbation in the degrees of freedom.
Allosteric transmission constitutes a change in degrees of freedom
at the G-protein-binding domain resulting from an initial per-
turbation. Mechanically, a change in conformation induced by a
binding ligand at one site may result in a change in shape or
conformation at a second site. The extent of coupling is evaluated
in terms of the presence of rigidity-transmission (change in
degrees of freedom) between these two sites. To explore this, we
sequentially perturbed the rigidity of a window of three
consecutive residues (r, r+ 1, r+ 2) associated with extracellular
residues within ECL1, ECL2, and ECL3, and calculated the
degrees of freedom that could be transmitted from the extra-
cellular domain to the G-protein-binding region, defined by
residues 208, 230, and 291 at the ends of TM5, 6, and 7 (Fig. 7a).
Residues were labeled as allosteric hot spots based on the intensity
of transmission of degrees of freedom. This exercise was repeated
for conformers generated from MD simulations and represented
in Fig. 5b–e. As shown in Fig. 7b, using the active state crystal
structure (PDB ID: 2YDO), rigidifying divalent cation bridges
E151-E161, E151-E169-D170, and D261-170 significantly
increased the intensity of degrees of freedom transmission (DOF),
suggesting that restrictions imposed by cation bridges are
allosterically propagated in the form of rigidity-transmission to
the G-protein-binding region.
Discussion
In the current study, we were able to recapitulate prior observa-
tions of negative allosteric effects of sodium, albeit in terms of
direct observations of changes in state populations. Here we also
observe an enhancement of the fraction of both inactive (S1−2)
and active (S3) conformers over a modest range of sodium
chloride concentrations, at the expense of the fully active state,
S3′. Of particular interest, the population ratio of S3 to S12 con-
formers increases at much higher sodium concentrations, sug-
gestive of a second lower affinity Na+ binding site that might
further stabilize the S3 activation intermediate. Recent 23Na NMR
binding isotherms of A2AR, performed in the presence of satur-
ating amounts of the agonist (NECA) also reveal the presence of a
sodium-binding site, despite the fact that there is no substantial
inactive conformer (unpublished results). Given that X-ray crystal
structures of NECA-stabilized A2AR do not show evidence for
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bound sodium, it is therefore likely that the activation inter-
mediate, S3, known to be stabilized by partial agonist, can also
bind Na+.
Sodium interactions are observed to be transient and dynamic,
based on 23Na CPMG relaxation dispersion measurements at
multiple fields. In this study, the average residency time of a
sodium ion in apo A2AR is found to be 480 μs. As sodium is part
of an extensive allosteric water network in the inactive state, its
release from the primary binding site in apo A2AR may also allow
for transient excursions to active conformations, thereby facil-
itating basal activity in class A receptors. Normally, the sodium-
binding site would be expected to be rapidly replenished by the
extracellular pool of sodium ions. However, binding by agonist
would block such access and bias egress of sodium toward the
intracellular milieu (i.e. down the sodium concentration gra-
dient), potentially affording free energy to the activation process
as has been elegantly hypothesized.22 The observation that the
activation intermediate, S3, is also stabilized by sodium corro-
borates the idea that sodium dynamics and its eventual cytosolic
egress is intrinsically involved in the activation process and that
intermediate binding sites may be involved in the egress of
sodium35.
19F NMR and 23Na NMR results suggest that the addition of
inverse agonist both increases the inactive conformer population
and the average Na+-bound state lifetime (i.e. 630 μs), thereby
curtailing excursions to activation intermediates or sampling of
other conformers. Prior studies have shown that the addition of
inverse agonist also leaves comparable populations of both the
inactive (S1−2) and activation intermediate (S3) states. Conse-
quently, the above average Na+-bound state lifetime will repre-
sent a weighted average between each of these two states and it
may be the case that the Na+-bound-state lifetime in the ZM-
stabilized inactive conformer is much longer. Note that the fits of
the 23Na CPMG dispersions to the apo A2AR data set are poorer
than those in the presence of inverse agonist. This likely relates to
the fact that the apo receptor consists of a broad ensemble of both
inactive and active-like conformers, whose affinities interaction
dynamics with sodium are quite different.
The positive allosteric effects associated with Ca2+ and Mg2+
on A2AR are also recapitulated in the 19F NMR spectra, albeit at
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Fig. 4 Radioligand binding assay in A2AR/Gs-infected Sf9 membranes. a Cations, Mg2+ or Ca2+, enhance specific [3H]NECA binding in A2A/Gs-infected
Sf9 membranes, while Zn2+ displayed reduced binding. b Specific [3H]NECA high affinity saturations ±2.5 mM Ca2+ or ±2.5 mM Mg2+. c Divalent cation,
Mg2+, enhances the affinity of NECA binding and the fraction of high affinity binding sites on A2AR in a G-protein-dependent manner. d Divalent cation,
Ca2+, enhances the affinity of NECA binding and the fraction of high affinity binding sites on A2AR in a G-protein-dependent manner. Error bars for
radioligand binding assays are defined based on three replicates
Table 1 Summary of effects of divalent cations on NECA inhibition of [3H]ZM241385
Membranes Cation Khigh (nM)b Klow (nM)b Fraction of Khigh (%)b
A2AR alonea Control 1781.00 ± 175.00
Mg2+ 1332.00 ± 82.00
Ca2+ 1533.00 ± 146.00
A2AR+Gs Control 14.10 ± 0.70 950.00 ± 97.00 26.60 ± 2.30
Mg2+ 9.18 ± 1.87 1060.00 ± 124.00 33.70 ± 2.03
Ca2+ 2.58 ± 0.58 708.00 ± 92.00 36.70 ± 1.88
a Data for A2AR alone were fit to a single site
b Khigh, Klow and fraction of Khigh were fitted using non-linear regression using
Prism software (GraphPad, La Jolla, CA)
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much higher concentrations. We also note that the receptor
concentrations used in the NMR studies are orders of magnitude
higher than those used in the radioligand studies. In insect cells,
we observed pronounced enhancement in NECA binding with
Mg2+ and Ca2+ concentrations of 350–400 μM, as discussed
above. Using 19F NMR in detergent-reconstituted receptors, we
observe clear enhancement in the fraction of active state con-
formers in the presence of saturating amounts of NECA and the
C-terminal Gαs peptide, using Mg2+ concentrations of 20 mM, as
shown in Supplementary Figure 5. This discrepancy in cation
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concentration between the NMR results and the radioligand
measurements may arise from the use of detergents to recon-
stitute the receptor or possibly, a cooperative interaction between
G protein, Mg2+, and receptor in cell membranes, not recapitu-
lated with the Gαs peptide used in the NMR experiments.
In the absence of high resolution X-ray crystal structures, our
understanding of the mechanism of positive allostery through
binding by divalent cations is limited. However, the all atom MD
simulations of A2AR in the presence of cations provide several
likely binding modes and means of positive allostery. Firstly, it
cannot be discounted that the divalent cations may bind in the
vicinity of the sodium-binding site in the active state, as suggested
by Fig. 5f, thereby establishing an allosteric network which may
help promote G protein binding. Also, binding of divalent cations
to E2286.30, which functions prominently in the ionic lock, would
clearly serve to screen electrostatic interactions with R1023.50,
thereby preventing excursions toward an inactive conformer,
effectively increasing the active state lifetime (Fig. 5h).
One possible mode of allosteric enhancement is expected to
arise from bridging of acidic residues, located in either ECL2 or
ECL3, by the divalent cations, as illustrated in Fig. 5a–e. In par-
ticular, E151-E161, E151-E169, and E151-D170, located on either
end of an extracellular helix within ECL2, and D170-D261 in
ECL3 were observed to establish long-lived electrostatic interac-
tions via an intervening divalent ion in the MD simulations. We
note that the crystal structure of agonist-bound A2AR reveals a
putative binding site between E169 and the purine group of the
agonist (PDB ID: 2YDO), while the majority of A2AR crystal
structures show the extracellular helix in ECL2 to be positioned
such that the above extracellular inter-residue contacts could not
be attained without conformational changes in the protein
backbone. However, it should be emphasized that in the active
state crystal structures of thermostabilized A2AR (PDB IDs:
2YDO) and at least one member of the unit cell of A2AR com-
plexed with G protein (PDB ID: 5G53) the extracellular helix is
constrained by crystal packing, while in a second active state
crystal structure (PDB ID: 3QAK) or a second unit cell member
of A2AR with G protein (PDB ID: 5G53), the extracellular helix is
disordered, in which case large amplitude conformational
excursions of ECL2 would be possible. The MD simulations
enable us to sample sub-states that are dynamically accessible
from the ground state crystal structure, free of crystal packing
effects, and in the presence of cations. While the above cation-
bridged interactions were observed to be long-lived by MD
standards (i.e. microsecond or longer), even transient bridging of
acidic residues by divalent cations would be expected to lower the
activation barrier toward sampling of active or intermediate
receptor states.
We note that the bridging of D170 and D261 by a divalent
cation, identified by MD simulations, brings the extracellular ends
of TM5 and TM6 in closer proximity (Fig. 5b), mechanically
facilitating the outward rotation of TM6 at the intracellular
interface (Fig. 8c–f). Indeed, as shown in Fig. 8a, b, D261-D170
inter-residue distances are clearly shortened in active state X-ray
crystal structures, in support of the idea that juxtaposition of the
extracellular facing ends of TM5 and TM6 helps to prop open
TM6 on the cytosolic face. Thus, in keeping with the above RTA
allostery transmission analysis, the close association of TM5 and
TM6 through these cation-mediated interactions has direct con-
sequences with regard to driving open the cytosolic G-protein-
binding cleft, as illustrated in Fig. 7b, c. Finally, binding of
divalent cations to E2286.30, which functions prominently in the
ionic lock, would clearly disfavor return to the inactive state upon
activation, as illustrated in Fig. 7d. In contrast to the above
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mechanism, effects of divalent cation interference with the ionic
lock would arise largely from the intracellular pool. Thus, extra-
and intracellular concentrations and compartmentalization would
be expected to give rise to pronounced local effects of divalent
cations.
The role of the extracellular acidic residues in facilitating
cation-mediated allostery has been previously considered by
Jacobson and colleagues, who focused on radioligand binding to
A2AR in transfected COS-712. In this case, acidic residues in the
second extracellular loop (E151, E161, E169, and D170) were
replaced with alanine or glutamine residues12. While they were
able to recapitulate the positive allostery on the part of Mg2+,
they were unable to identify a change in the allosteric response
based on agonist affinity resulting from either E161A or E169Q
mutations. Full stimulation of adenylyl cyclase was also observed,
albeit at thousand-fold higher agonist concentrations. A thorough
analysis of the implications in mutating these acidic residues
proved problematic given the gross changes in ligand binding
seen for most mutations12. Moreover, it is also possible that the
proposed allosteric effects resulting from bridging key acidic
residues arise from multiple transient and cooperative interac-
tions, as proposed in Fig. 5. Given the dual role of the extra-
cellular loops in negotiating ligand access and in cooperativity, it
would be difficult to perform a thorough analysis through
mutations of extracellular acidic residues. In this sense, the MD
studies can theoretically provide essential insight into the role of
the extracellular acidic residues in facilitating divalent cation
binding and contributing to the activation process.
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Bridging of acidic residues by divalent cations appears to be
spontaneous and relatively stable from the perspective of MD
simulations over 1 μs trajectories, though it is not clear if this is
physiologically relevant since very high divalent cation con-
centrations were used in the MD study. In this case, a conserved
divalent ion binding site, resulting from a conformational tran-
sition could be missed without an appropriate MD starting
structure. However, we note that 19F NMR studies, which
investigated the role of divalent cations in the presence of agonist
and Gαs peptide, showed that 20 mM Mg2+ resulted in an
obvious increase in the active S3′ state population whereas Fe2+
did not (Supplementary Fig. 6), in keeping with radioligand
studies where both Fe2+ and Zn2+ gave no positive allosteric
effects. Assuming Ca2+, Mg2+, and Fe2+ would serve equally well
to bridge acidic residues, this could imply that divalent ion
facilitated bridging of acidic residues is not the primary allosteric
driving force at least at low divalent cation concentrations.
Rather, binding of full agonist and the interaction with G protein
bring about a unique coordination site that specifically facilitates
the observed allosteric effect via Ca2+ or Mg2+. The results
observed by MD studies at high cation concentrations are
nonetheless interesting from the perspective of pharmaceutical
strategies for positive allosteric modulators (PAMs). MD simu-
lations suggest a compaction of the extracellular domain of the
receptor by bridging acidic residues results in a significant
opening of the intracellular G-protein-binding cavity volume
(Fig. 8e, f) which is corroborated by rigidity theory. Thus, it may
be possible to purposefully design a PAM that recapitulates this
extracellular compaction, as was recently shown with the allos-
teric modulator, LY2119620, in studies of the M2 muscarinic
acetylcholine receptor36.
The above results point to an important relationship between
cations and GPCR function. First, the sodium-binding site
appears to be a common facet of class A GPCRs, and can be
traced to certain early microbial rhodopsins37. While sodium is a
recognized negative allosteric modulator, which predictably sta-
bilizes the inactive ensemble, its interaction with various states of
the receptor is observed to be transient, suggesting that sodium
may well undergo significant egress in the receptor, possibly
playing a role in activation22 or in facilitating basal excursions to
activation intermediates. 19F NMR provides the means to directly
quantify the stabilizing effects of sodium on the conformational
ensemble, with the surprising result that the activation inter-
mediate, S3, linked earlier to partial agonism, is also stabilized by
sodium. Moreover, 23Na CPMG measurements provide quanti-
tative measures of cation interaction dynamics in these receptors,
and therefore allow us to elaborate on cation-mediated activation
mechanisms.
The positive allostery observed with the divalent cations Ca2+
and Mg2+ stand in contrast to the negative allostery observed
with sodium, although all ions appear to stabilize pre-exisiting
states in a manner consistent with conformational selection1. MD
simulations and rigidity theory calculations point to a
possible role of these divalent cations in bridging key acidic
residues at high cation concentrations, thereby helping establish
an allosteric activation pathway to the G-protein-binding region.
These studies suggest that one possible means of achieving
positive allosteric modulation is to compact the extracellular
regions.
Overall, 19F NMR reveals pronounced effects of both Na+ and
either Mg2+ or Ca2+ on the population of functional receptor
states. Moreover, this is fully recapitulated in radioligand assays
in cell membranes at sub-millimolar concentrations. 23Na (Fig. 2)
and 25Mg NMR (Supplementary Fig. 7) show that these inter-
actions operate on a millisecond timescale, underlining their role
in “dynamically” influencing the activation process.
Methods
Gene operation and receptor purification. The construct pPIC9K_Fα-Factor-
Flag-TEV-A2aARTr316-H10_V229C containing the V229C mutation was gener-
ated using a QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent
Technologies) according to the manual of the Kit using a single primer1 of 5′-
CCACACTGCAGAAGGAGTGCCATGCTGCCAAGTCAC-3′. Freshly prepared
competent cells of the SMD 1163 strain (Δhis4 Δpep4 Δprb1, Invitrogen) of Pichia
pastoris (ATCC® 28485™; Invitrogen, CA, USA) were electro-transformed with
PmeI-HF (New England Biolabs) as linearized plasmids by a Gene Pulser II (Bio-
Rad). High copy clone selection was performed by a two-stage screening approach
established in-house29,38. The transformants were first spread on histidine-deficient
YNBD plates. After 3–5 days incubation at 30 °C, the resulting colonies were
transferred individually onto YPD plates containing 0.25 mg/mL G418 for another
incubation of 3–5 days at 30 °C. The colonies were subsequently transferred to
YPD plates containing 2 mg/mL G418 for an additional incubation period of
5–7 days and then further transferred onto YPD plates containing 4 mg/mL G418
and incubated for another 5–7 days. One of the surviving colonies was then
selected to make competent cells for second-cycle screening. After transformation,
the secondary transformants were directly spread onto YPD plates with different
G418 concentrations (2 mg/mL and 4 mg/mL), rather than YNBD plates. The
colonies that grew on 4mg/mL G418 YPD plates were further transferred onto 6
mg/mL G418 YPD plates for an additional 5–7-day incubation period. Ten to 15
high-copy colonies picked from YPD plates containing 6 mg/mL G418 were then
screened by an immunoblotting assay for further expression.
Reconstitution and functional purification of the high-yield construct was
performed as follows1: After expression, the cell pellets were washed one time with
buffer P1 (50 mM HEPES, pH 7.4) and re-suspended in Lysis buffer P2 (50 mM
HEPES, pH 7.4, 100 mM NaCl, 2 mM EDTA, 10% glycerol, 100 U Zymolyase,
EDTA-free-proteinase inhibitor) at a ratio of 1:4 (W/V) and left standing for 1 h at
room temperature. Yeast cell walls were further disrupted by vortexing for 2 h at 4 °
C in the presence of 5 mm glass beads, which were added to the re-suspended cells.
Intact cells and cell debris were separated from the membrane suspension by low
speed centrifugation (8000 × g, 20 min, 4 °C). The supernatant was collected and
centrifuged at 100,000 × g for 1 h and the resulting membrane pellets were then
dissolved in 25 mL buffer P3 (50 mM HEPES, pH 7.4, 100 mM NaCl, 2 mM
theophylline, 10% glycerol, EDTA-free-protease inhibitor, solution of 1% lauryl
maltose neopentyl glycol (MNG) (Anatrace), 0.2% CHS, and 20 mM imidazole)
under continuous shaking for about 1–2 h at 4 °C. TALON® Metal Affinity Resin
was then added into re-suspended membranes under gentle shaking for 2 h
overnight at 4 °C. The receptor conjugated resin was washed extensively with buffer
P4+ 1 (50 mM HEPES, pH 7.4, 100 mM NaCl, 4 mM theophylline, 10% glycerol,
EDTA-free-protease inhibitor, solution of 0.1% MNG and 0.02% CHS) to remove
non-conjugated receptor and impurities in solution. The receptor was eluted from
the TALON resin column after addition of 10 column volumes of buffer P5 (50
mM HEPES, pH 7.4, 100 mM NaCl, 10% glycerol, solution of 0.1 % MNG and
0.02% CHS, 250 mM imidazole). The eluant was then concentrated to 5 mL and
concentrations of NaCl, imidazole, and theophylline were decreased by washing
with buffer P6 (50 mM HEPES, pH 7.4, 0.1% MNG, 0.02% CHS). The receptor was
then incubated with XAC-agarose gel for at least 1 h with gentle shaking to allow
for the receptor binding to XAC-agarose. The receptor-conjugated XAC-agarose
was packed on a disposable column. The column was washed with buffer P7 (50
mM HEPES, pH 7.4, 0.1% MNG, 0.02% CHS, 100 mM NaCl) to remove non-
bound receptor. The receptor was then eluted with buffer P8 (50 mM HEPES, pH
7.4, 0.1% MNG, 0.02% CHS, 100 mM NaCl, 20 mM theophylline). The eluant was
then concentrated into 1–2 mL and dialyzed extensively against buffer P7 (50 mM
HEPES, pH 7.4, 0.1% MNG, 0.02% CHS, 100 mM NaCl) prior to NMR
experiments.
Reagents and biochemical assay. Receptor concentrations were measured via a
Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, USA) using bovine
serum albumin as a standard. Agonist 5′-(N-ethylcarboxamido) adenosine (NECA)
was purchased from Sigma-Aldrich. 2-bromo-N-[4-(trifluoromethyl)phenyl]acet-
amide (BTFMA) was purchased from Apollo Scientific (Manchester, United
Kingdom). Gαs peptides (RVFNDARDIIQRMHLRQYELL)29 used in the study
were purchased from China Peptides (Shanghai, P.R. China), whose purities were
verified to be over 95% by HPLC. Labeling of the Gαs peptide was achieved by
addition of 10× BTFMA, followed by gentle stirring for 6 h at room temperature.
An equivalent aliquot of BTFMA was then added to the solution followed by gentle
stirring for an additional 6 h to ensure complete labeling of the peptide. The
BTFMA-labeled peptide was centrifuged at 4000 × g for 5 min, and the supernatant
was extensively dialyzed against HEPES buffer (pH 7.4). The final concentration of
BTFMA-labeled peptide was estimated by 19F-NMR.
19F NMR experiments. NMR samples typically consisted of 250 μL volumes of
25–200 μM A2AR-V229C in 50 mM HEPES buffer (pH 7.4) and 100 mM NaCl,
doped with 10% D2O. The receptor was stabilized in 0.1% MNG-3 and 0.02% CHS.
All 19F NMR experiments were performed on a 600MHz Varian Inova spectro-
meter using a cryogenic triple resonance probe, with the high frequency channel
tunable to either 1H or 19F. Typically, the 90° excitation pulse was 23 μs, the
acquisition time was 200 ms, the spectral width was set to 15 kHz, and the
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repetition time was 1 s. Most spectra were acquired with 10,000–50,000 scans
depending on sample concentration. Processing typically involved zero filling, and
exponential apodization equivalent to 20 Hz line broadening.
23Na+ NMR experiments. The experiments were performed on a 600MHz
Varian VNMRS spectrometer using a room temperature XH broadband probe (X-
nucleus on the inner coil). Additional 23Na NMR measurements were performed
on an Agilent DD2 700-MHz spectrometer using OneNMR direct detect broad-
band probe. 23Na+ NMR experiments were performed in the presence of either 50
μM or 25 μM A2AR. An external 23Na reference was prepared by mixing 50 mM
NaCl and 50 mM TmCl3 in equal volumes prior to loading into the coaxial insert.
The resultant 23Na reference was conveniently shifted downfield by 4 ppm from
the free sodium chloride signal associated with the receptor sample. A typical
experimental setup included a 7.5 μs 90° excitation pulse, an acquisition time of
250 ms, a spectral width of 15 kHz, and a repetition time of 1.25 s. Most spectra
were acquired with 512 scans and yielded a signal to noise ratio greater than 100.
Information regarding binding can be reliably obtained by observing the shift of
the free peak and line broadening associated with fast exchange between “free” and
“bound” states.
25Mg2+ NMR experiments. The experiment was performed on an Agilent DD2-
600 NMR, equipped with a 10 mm low gamma direct detect probe and low fre-
quency pre-amp. The experimental parameters used were as follows: 20 °C, a
Larmor frequency of 36.72 MHz, a spectral width of 2.5 kHz, 1.1 s acquisition time,
0.5 s relaxation time, a 30 µs 90° excitation pulse, and between 128 and 2048 scans
depending on the signal-to-noise ratio. For the Kd determination of Mg2+ the
following protocol was used: A 1M MgCl2 solution with 10 mM DyCl3 in D2O was
used as a reference and was placed in a 5-mm OD tube. A sample of 1.5 mL of the
protein solution was placed in a 10-mm OD NMR tube. The reference tube was
thoroughly cleaned and inserted into the 10-mm tube and centered with a plastic
cap. Titration volumes of 3–37 µL of 4.64 M MgCl2 were added directly to the 10-
mm tube which was then gently mixed using a vortex shaker. The sample was
allowed to equilibrate in the magnet for 10 min at the set temperature and the
sample was then locked, tuned, gradient shimmed and acquired. To determine Ki
associated with Ca2+ displacement of Mg2+, 1.3–14.7 µL of 5.0 M CaCl2 was added
directly to the Mg2+ saturated receptor dispersion which was then gently mixed
using a vortex shaker. The sample was allowed to equilibrate at the set temperature
in the magnet for 10 min and then locked, tuned, gradient shimmed and acquired.
The Kd and Ki values were determined, using GraphPad Prism 6 software, by fitting
the data to the formula, y=A × x/(Kd+ x), where x represents the cation
concentration.
A2AR-Gs protein co-expression and radioligand binding assays. Sf9 cells
(ATCC®CRL1711TM; Invitrogen, CA, USA) were infected with baculoviruses to
A2AR receptor alone (MOI~1) or together with Gαs. For Gαs coinfections the cells
were infected with A2AR (MOI~1.0) with Gαs and Gβγ viruses (MOI~5.0 and 3.5
respectively), to ensure satisfactory expression of Gαs and functional coupling. Post
infection, cultures were grown/incubated for 48 h followed by centrifugation to
pellet the cells. Membranes were prepared first by resuspension of Sf9 pellets into
30 mL of 10 mM HEPES, 10 mM NaCl, 0.5 mM MgCl2, 0.5 mM EDTA, pH 7.4
(buffer A) and homogenized before centrifugation at 20,000 × g for 20 min. The
pellet was again re-suspended in 30 mL of (buffer A), homogenized and centrifuged
20,000 × g for 20 min. The remaining pellet was then re-suspended to ~1.0 mg/mL
by dounce homogenization in 10 mM HEPES, 10 mM NaCl, 0.5 mM EDTA, pH
7.4 (buffer B) and flash frozen until further use.
Radioligand binding assays: Radioligand binding assays were performed on a
96-well format in a final volumes of 200 µL in 10 mM HEPES pH 7.4 including 100
mM NaCl. Prior to use, membranes were thawed and diluted to appropriate
concentrations in buffer B. Two micrograms of membrane protein/well were
incubated with radioligand (either agonist [3H]NECA or inverse agonist [3H]
ZM241385) in the absence or presence of divalent cations (MgCl2 or CaCl2). For
[3H]NECA saturations, membranes at 6 μg protein/well were incubated with
increasing concentrations of radioligand (as indicated) in the presence of 2.5 mM
MgCl2 or 2.5 mM CaCl2, or buffer alone. For divalent cation dose−response curves,
membranes were incubated with 10 nM [3H]NECA in the presence of increasing
concentrations of divalent cations: MgCl2, CaCl2, or ZnCl2. For NECA
competitions of [3H]ZM241385, membranes (A2AR alone or A2AR+Gs) were
incubated with 2 nM [3H]ZM241385 and increasing concentrations of unlabeled
NECA (as indicated) in the absence or presence of 2.5 mM MgCl2 or CaCl2. For
A2A membranes data were fit to a single site since no high affinity NECA binding is
observed whereas A2AR+Gs membranes were fitted to a two-site model. All data
were fitted using Prism software (Graphpad, La Jolla, CA). All incubations were
performed for 3 h at 25 °C. Reactions were initiated through the addition of
membranes and terminated by rapid filtration on glass fiber 96-well microtiter GF/
C filter plates, followed by washing with 3× volume of cold, 4 °C, buffer B.
MD simulations of cation distributions. Simulation systems comprised apo A2AR
in a hydrated zwitterionic lipid bilayer with Na+, K+, Ca2+, Mg2+, and Zn2+ at
100 mM each and Cl− at 800 mM. Three sets of five 1-μs simulations were
conducted, using an initial crystal structure of A2AR obtained with either the
endogenous agonist adenosine (PDB 2YDO)30 or the synthetic agonist UK-432097
(PDB 3QAK)31 or the agonist NECA and an engineered G protein (PDB 5G53)27.
System construction of MD simulations. Extracellular ligands, water molecules,
and other solvents resolved in crystal structures were removed. Missing backbone
atoms were modeled with the program Loopy42,43. Missing side chain atoms and
side chain reversions to wild-type were modeled with the program SCWRL444.
Disulfide bonds (C71-C159, C74-C146, C77-C166, and C259-C262) and all
hydrogen atoms were placed with the GROMACS tool pdb2gmx38, and the
receptor was then energy minimized. The simulated receptor was not glycosylated,
all titratable residues were in their standard states for pH 7, and the protein
backbone termini were zwitterionic.
A unique bilayer conformation was constructed for each simulation. To this
end, a configuration of a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) bilayer with 200 (2YDO simulations) or 166 (3QAK and
5G53 simulations) lipids per leaflet was obtained from the CHARMM-GUI45
membrane builder46, solvated with 80 water molecules per lipid, energy minimized,
and simulated for 300 ns. A snapshot was extracted at a random time between 50
and 300 ns, translated by a random distance in the bilayer plane (resetting the
periodic unit cell), and (randomly) in some cases rotated by 180° to exchange
upper and lower leaflets.
The receptor was oriented for insertion into the lipid bilayer using the program
LAMBADA47, and embedded in the bilayer using 20 cycles of the InflateGRO2
routine47 with double-precision GROMACS steepest descent energy minimization.
During this procedure, 12–17 lipids were removed from each leaflet, allowing the
final numbers to be asymmetric. Each system was hydrated, disallowing water in
the bilayer’s hydrophobic core, and ions were added at random locations at least
0.8 nm away from protein, lipid or any other ions. Following energy minimization,
the solvent (including lipid and ions) was relaxed over 30 ns without unduly
perturbing the receptor by conducting sequential 5-ns simulations using position
restraints on: (a) receptor heavy atoms with force constants of 104 and 103 kJ/mol/
nm2, and (b) receptor Cα atoms with force constants of 103, 102, 10, and 1 kJ/mol/
nm2. All restraints were then removed for production simulation. Each repeat uses
different models of missing receptor atoms.
Protein sequence used in MD simulations. Residue identifiers always corre-
sponded to the receptor’s full-length wild-type sequence (UNIPROT ID: P29274).
In our simulations, the adenosine-derived receptor sequence was Δ(M1-G5)
and Δ(A317-S412); the UK-432097-derived receptor sequence was Δ(M1-P2)
and Δ(R309-S412); and the NECA-derived receptor sequence was Δ(M1-G5) and
Δ(L308-S412).
Simulation parameters. Molecular dynamics simulations were conducted with a
single-precision compilation of version 4.6.7 of the GROMACS simulation pack-
age38. Macromolecules were modeled by the CHARMM 22 protein force field39
with grid-based energy correction maps40, and the CHARMM 36 lipid force field41
as implemented in GROMACS48,49. The water model used in the simulation was
TIP3P50 with CHARMM modifications39. Water molecules were rigidified with
SETTLE51 and bond lengths in protein and lipid were constrained with P-LINCS52
using sixth-order coupling and a single iteration. Lennard−Jones interactions were
evaluated using an atom-based cutoff, gradually switching off the potential energies
of interactions between 0.8 and 1.2 nm. Coulomb interactions were calculated using
the smooth particle-mesh Ewald (PME) method53,54 with a Fourier grid spacing of
0.12 nm. Simulation in the NpT ensemble was achieved by semi-isotropic coupling
to Berendsen barostats55 at 1 bar with compressibilities of 4.5×10−5/bar and
coupling constants of 4 ps; temperature-coupling was achieved using velocity
Langevin dynamics56 at 310 K with a coupling constant of 1 ps. The integration
time step was 2 fs. The nonbonded pairlist was updated every 20 fs. Position-
restrained equilibration periods were omitted from all statistical analyses.
Rigidity-based allosteric communication. To probe the allosteric transmission
between the extracellular domain and the intracellular G-protein-binding region,
we utilized the RTA algorithm, a computational approach based on rigidity the-
ory57 and an extension of the FIRST method58. The RTA algorithm is founded on
rigidity theory, initially introduced in 201259,60, and further discussed by Whiteley
et al. 61. RTA predicts the extent to which a perturbation of rigidity at one binding
site can be allosterically transmitted to a second distant site. Starting with an X-ray
crystal structure, FIRST generates a constraint network, where the protein is
modeled in terms of nodes (atoms) and edges (i.e. constraints representing covalent
bonds, hydrogen bonds, electrostatic interactions, and hydrophobic contacts).
Hydrogen bonds are ranked in terms of overall strength using a Mayo potential58,
whereupon a hydrogen bond energy cutoff value is selected such that all bonds
weaker than this cutoff are ignored. FIRST then applies the pebble game algo-
rithm32,57 that rapidly decomposes a resulting network into rigid clusters and
flexible regions, enabling an evaluation of non-trivial degrees of freedom (DOF)
throughout the protein.
After generating the output of FIRST we applied the RTA algorithm to predict if
local mechanical perturbations of rigidity at extracellular binding regions
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(mimicking ligand binding) could propagate across the protein network (TM
region) and lead to a quantifiable change in rigidity and conformational degrees of
freedom at the intracellular G-protein-binding region, hence resulting in allosteric
transmission. Equivalently, presence of rigidity-based allostery means that a change
in shape (conformation) at one site could lead to rearrangement and change of
shape of the second site. The number of conformational degrees of freedom at the
intracellular G-protein-binding region was calculated before and after a sequential
perturbation of rigidity of all residues at the extracellular region. Those residues
whose rigidity perturbation induced a change in degrees of freedom (transmission
of degrees of freedom through propagation of rigidity) at the intracellular region
were identified as predicted allosteric sites. Residues were labeled as hot allosteric
spots based on the amount of transmission of degrees of freedom.
Rigidity transmission allostery computation. To prepare the crystal structure for
rigidity and allostery analysis, missing hydrogen atoms were added using the
WHAT IF web server (http://swift.cmbi.ru.nl/servers/html/htopo.html). Starting
with the N-terminus, we sequentially perturbed the rigidity of a window of three
consecutive residues (r, r+ 1, r+ 2) and calculated the degrees of freedom that
could be transmitted from the current window to the G-protein-binding region.
Perturbation of rigidity refers to insertion of additional constraints (edges)
(removal of degrees of freedom) to the window up to its rigidification. If rigidity-
based allostery is present, transmission of degrees of freedom refers to a subsequent
change in the available number of degrees of freedom at the G-protein-binding
region. Based on the recent X-ray crystal structure of the A2AR-G protein complex,
we define residues 208, 230, and 291 located at the ends of TM5-7 respectively, to
designate the G-protein-binding interface.
The RTA algorithm computes the transmission of degrees of freedom between
any two sites. Denoting the current tested window as site A, and the G-protein-
binding region as site B, we calculate the available conformational degrees of
freedom at site A, site B and the union of sites A and B. This exercise is repeated
upon successively omitting weak energy constraints in increments of 0.01 kcal/mol.
Given some fixed energy cutoff, we denote these degrees of freedom counts as Amax,
Bmax, and ABmax, respectively (these counts were calculated using the pebble game
algorithm). The maximum number of degrees of freedom that can be transmitted
from A to B (denoted as DOF_AB) is finally calculated by obtaining the count
DOF_AB= Amax+ Bmax−ABmax− 6. Six is subtracted to neglect the trivial
degrees of freedom corresponding to rigid body motions. When DOF_AB is
positive, then sites A and B are involved in rigidity-based allosteric transmission
and the maximum number of degrees of freedom that can be transmitted from A to
B is DOF_AB. This provides a quantifiable measure of allosteric communication
between A and B. To observe allosteric transmission for some residue r, a
transmission curve was generated by plotting the average DOF_AB for three
consecutive windows containing r [i.e. (r− 2, r− 1, r), (r− 1, r, r+ 1) and (r, r+ 1,
r+ 2)] as a function of the energy cut-off. We calculated the intensity of allosteric
transmission for each window by computing the area under the transmission curve.
The intensity of allosteric transmission for residue r was obtained by computing the
average intensity of the three consecutive windows containing the residue r. Note
that the intensity of allosteric transmission takes into account the number of
degrees of freedom that can be transmitted and the persistence of the transmission
as a function of energy strength. If allostery persists for a wide range of cutoffs, then
slight changes in the hydrogen bonding network (e.g. hydrogen bond flickering)
are more likely to keep the allosteric transmission active.
HMA docking. Docking was performed using Autodock Vina62 version 1.1.2. Prior
to docking, all non-protein structures (ions, lipids, waters) were stripped from
PDB: 4EIY. PDBQT structures of HMA (5-(N, N-Hexamethylene) amiloride) and
the receptor were prepared using MGLTools version 1.5.6 (AutoDockTools). All
single bonds in HMA were made rotatable. A box defining the docking site was
created using the following parameters: center_x=−1.723, center_y=−12.253,
center_z= 18.125, size_x= 18, size_y= 20, size_z= 20. The lowest energy pose for
the docked HMA was selected and structures were visualized in VMD 1.9.163.
Data availability. Data supporting the findings of this manuscript are available
from the corresponding author upon reasonable request.
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